News
Court of Appeal backs Astellas in UK patent fight over prostate cancer drug | Generics’ challenge fails as judges warn on ...
27 May 2025 Litigation concerns Novartis’ blockbuster $6bn heart failure drug, which has already expired | Indian generic ...
$56M awarded to AbbVie unit in Delaware patent fight over Botox treatment | US Botox sales reportedly grew to over $4.4 billion last year, while trade secrets lawsuit against rival continues. Already ...
Delhi High Court has granted an interim injunction against Zydus Lifesciences over the company’s proposed nivolumab product | ...
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...
New hire is deeply involved in the litigation space and has co-founded two software businesses. If you don't have a login or ...
29 April 2025 EWHC ruling discusses application of EPO case law regarding lack of plausibility and lack of technical ...
The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for ...
For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...
31 March 2025 With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its ...
After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...
Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results